Definitive Contract 75F40122C00057

Award Date 4/29/22
Potential Completion Date 5/1/24
Potential Value $2.5M
Awardee
Agisol LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Daniels, MD 21043, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,499,944.46 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for 2 years of business process user support to the FDA's Center for Drug Evaluation and Research (CDER). This is a direct 8(a) award with no set-aside used. Agisol LLC is an IT services and solutions provider that has previously supported the FDA's regulatory...
This is a federal contract award to Agisol LLC, a small business and SBA-certified 8(a) Program participant, by the U.S. Food and Drug Administration (FDA). The contract is valued at $2,538,816.41 and provides office support services for the FDA's Office of Clinical Policy. The contract is a delivery order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions managed by the General Services...
This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including...
The Food and Drug Administration (FDA) awarded an $4,494,448.70 firm-fixed-price delivery order contract to Agilistek LLC, an 8(a) small disadvantaged business, to provide development, enhancement, and maintenance services for the agency's Foreign Inspection Planning and Scheduling System (FIPSS). This contract is a task order issued under Agilistek's prime 8(a) STARS III Governmentwide Acquisition Contract (GWAC), a $50 billion multiple-award vehicle managed by the General Services...
This is a $3,465,935.06 delivery order awarded to Technology Solutions Provider, LLC, a minority-owned small disadvantaged business, under the 8(a) STARS II Government-Wide Acquisition Contract (GWAC) vehicle managed by the General Services Administration. The contract is to provide architecture and engineering services for the Office of Information Management and Technology (OIMT) Chief Technical Officer (CTO) at the Food and Drug Administration (FDA), a civilian agency. The award was made...
This is a $1,039,247.81 firm-fixed-price Delivery Order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to DRT Strategies, Inc., a minority-owned, small disadvantaged, woman-owned business. The contract was competitively set aside for 8(a) firms. Under this order, DRT Strategies will provide information technology (IT) solutions, health information management, program management, and financial management...
Agilistek LLC, a minority-owned small business certified as an 8(a) Small Disadvantaged Business, was awarded a $2,808,691.95 sole source delivery order under the 8(a) STARS III Governmentwide Acquisition Contract (GWAC) to provide Phase 4 development, enhancement, and maintenance support for the Food and Drug Administration's (FDA) Foreign Inspection Planning and Scheduling System (FIPSS) from September 2023 to September 2024. This 8(a) set-aside contract will be executed using labor hour...
This is a $11,802,344.74 delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Deloitte Consulting LLP, doing business as Deloitte, to provide enterprise data architecture and regulatory review support services for the Center for Drug Evaluation and Research (CDER). The contract is under the GSA IT Schedule 70 program and does not have a set-aside designation. Key subcontractors include Executive Information Systems LLC for...
This federal contract award from the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) is for the modernization of several FDA offices, including the Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), Office of Translational Sciences (OTS), and the Office of Orphan Products Development (OOPD). The contract, valued at $2,169,543.28, was awarded to DRT Strategies, Inc., a minority-owned, woman-owned small business, on July 19, 2019. The...
This is a $2,190,060.80 delivery order awarded to Arlluk Technology Solutions LLC, a subsidiary of Alaskan Native Corporation Koniag, Inc., under the GSA Multiple Award Schedule (MAS) program. The award is for CAAS O&M Infrastructure Support Services for the Food and Drug Administration (FDA), a civilian federal agency. Arlluk is an 8(a) certified small disadvantaged business that provides a range of IT services to federal agencies, including cloud migration, software development,...

This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER), and systems/data support for drug evaluation and research. Agisol holds a prime position on the GSA's $50 billion 8(a) STARS III GOVERNMENTWIDE ACQUISITION CONTRACT (GWAC), through which it has received over $4.6 million in task orders from HHS FDA. Agisol also holds a GSA Multiple Award Schedule contract, through which it has received over $5.7 million in delivery orders for CDER regulatory review systems support and process documentation/development services.

Generated 5/21/24, 9:49 AM